What’s Trending This Winter
The Real Deal
Stacey Simms knows she isn’t perfect, and she’s happy to let the world know it, too. The diabetes blogger, speaker, and podcast host is also mom to teen son Benny, who has type 1 diabetes. In her new book, The World’s Worst Diabetes Mom, Simms humorously chronicles her parenting ups and downs—such as the time she had to figure out how to check her sleeping 2-year-old’s blood glucose through crib slats—while doling out tried-and-true advice to fellow diabetes caretakers. $15; available from amazon.com and diabetes-connections.com.
Also on Our Radar
Save on Meds
Insulin users, take note: Beginning in January, Novo Nordisk will offer a cash card that can be used to purchase up to three vials of its analog insulins or two packs of insulin pens—roughly a month’s supply at 100 units per day—for a flat cost of $99 (more at novonordisk.com). This comes on the heels of Eli Lilly’s announcement last year that it had begun selling half-priced versions of Humalog, called Insulin Lispro Injection (get more details here). Also offering help: Sanofi, which last year began limiting the amount insured and uninsured patients pay for Lantus and Toujeo insulins to no more than $99 per month for up to 10 vials or packs of pens (learn more at insulinsvalyou.com).
It’s getting easier to treat severe hypoglycemia. First came Eli Lilly’s nasal glucagon, Baqsimi. Now there’s Gvoke. Xeris Pharmaceuticals’ Gvoke prefilled glucagon syringe comes premixed for quicker delivery. Users remove the device cap, insert the needle into the skin, and push the plunger down. It’s available in two doses—one for adults and one for kids ages 2 and older—and has a shelf life of two years. $280 per dose before insurance, gvokeglucagon.com.